WBR0469: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m refreshing WBR questions |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{ | |QuestionAuthor= {{YD}} (Reviewed by {{YD}} and {{AJL}}) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Biochemistry | |MainCategory=Biochemistry | ||
Line 8: | Line 8: | ||
|MainCategory=Biochemistry | |MainCategory=Biochemistry | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|MainCategory=Biochemistry | |||
|MainCategory=Biochemistry | |MainCategory=Biochemistry | ||
|MainCategory=Biochemistry | |MainCategory=Biochemistry | ||
Line 20: | Line 21: | ||
|MainCategory=Biochemistry | |MainCategory=Biochemistry | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|Prompt= | |Prompt=An 6-month-old boy is brought by his mother to the pediatrician's office for failure to thrive, persistent diarrhea, and steatorrhea. Peripheral blood smear reveals acanthocytosis with undetectable plasma cholesterol and triglyceride. Which of the following disorders is the primary defect in this patient's condition? | ||
|Explanation=[[Abetalipoproteinemia]] | |Explanation=[[Abetalipoproteinemia]] is a rare autosomal recessive genetic disease characterized by fat accumulation in enterocytes, fat malabsorption, acanthocytosis, and hypocholesterolemia. Abetalipoproteinemia is caused by mutations in the ''MTP'' gene (long arm of chromosome 4) that encodes microsomal triglyceride transfer protein (MTP or MTTP). MTPs are required for the synthesis and post-translational processing of apo-B. As such, abetalipoproteinemia is marked by the complete absence of apo-B-containing [[lipoproteins]], namely VLDL, LDL, and [[chylomicrons]]. At older age, [[abetalipoproteinemia]] frequently manifests with clinical signs and symptoms associated with fat-soluble vitamin deficiency. Patients often present with complaints related to the GI (steatorrhea and fat malabsorption), ocular (atypical retinitis pigmentosa), hematological (coagulopathy), and neurological (posterior column neuropathy) systems. | ||
|AnswerA=Defect in LDL receptors | |||
|AnswerA=Defect | |||
|AnswerAExp=A defect in LDL receptors frequently results in [[familial hypercholesterolemia]] (FH). | |AnswerAExp=A defect in LDL receptors frequently results in [[familial hypercholesterolemia]] (FH). | ||
|AnswerB=Defect | |AnswerB=Defect in apolipoprotein B | ||
|AnswerBExp=Although | |AnswerBExp=Although apo-B synthesis is affected in individuals with [[abetalipoproteinema]], an apo-B defect is not the primary detect that leads to [[abetalipoproteinema]]. | ||
|AnswerC=Defect | |AnswerC=Defect in microsomal triglyceride transfer protein | ||
|AnswerCExp=A defect | |AnswerCExp=A defect in the ''MTP'' gene results in [[abetalipoproteinemia]]. | ||
|AnswerD=Defect | |AnswerD=Defect in lipoprotein lipase | ||
|AnswerDExp=A defect in lipoprotein lipase (LPL) | |AnswerDExp=A defect in lipoprotein lipase (LPL) results in [[chylomicronemia]] | ||
|AnswerE=Defect | |AnswerE=Defect in chylomicron | ||
|AnswerEExp=A defect in [[chylomicron]] is not the primary defect in individuals with [[abetalipoproteinemia]], but often it occurs secondary to an MTP gene defect. | |AnswerEExp=A defect in [[chylomicron]] is not the primary defect in individuals with [[abetalipoproteinemia]], but often it occurs secondary to an ''MTP'' gene defect. | ||
|EducationalObjectives=[[Abetalipoproteinemia]] results from a genetic mutation in the ''MTP'' gene. | |||
|References=Aggerbeck LP, Bouma ME, Eisenberg C, et al. Absence of microsomal transfer protein in individuals with abetalipoproteinemia. Science. 1992;258(5084):999-1001.<br> | |||
Zamel R, Khan R, Pollex RL, et al. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis. 2008;3:19.<br> | |||
First Aid 2014 page 353 | |||
|RightAnswer=C | |RightAnswer=C | ||
|WBRKeyword= | |WBRKeyword=Abetalipoproteinemia, Malabsorption, Diarrhea, Microsomal triglyceride transfer protein, Apolipoprotein, MTP, MTTP, Apo-B, Acanthocytosis | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} |
Latest revision as of 00:41, 28 October 2020
Author | [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Yazan Daaboul, M.D. and Alison Leibowitz [1])]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Biochemistry |
Sub Category | SubCategory::Gastrointestinal |
Prompt | [[Prompt::An 6-month-old boy is brought by his mother to the pediatrician's office for failure to thrive, persistent diarrhea, and steatorrhea. Peripheral blood smear reveals acanthocytosis with undetectable plasma cholesterol and triglyceride. Which of the following disorders is the primary defect in this patient's condition?]] |
Answer A | AnswerA::Defect in LDL receptors |
Answer A Explanation | [[AnswerAExp::A defect in LDL receptors frequently results in familial hypercholesterolemia (FH).]] |
Answer B | AnswerB::Defect in apolipoprotein B |
Answer B Explanation | [[AnswerBExp::Although apo-B synthesis is affected in individuals with abetalipoproteinema, an apo-B defect is not the primary detect that leads to abetalipoproteinema.]] |
Answer C | AnswerC::Defect in microsomal triglyceride transfer protein |
Answer C Explanation | [[AnswerCExp::A defect in the MTP gene results in abetalipoproteinemia.]] |
Answer D | AnswerD::Defect in lipoprotein lipase |
Answer D Explanation | [[AnswerDExp::A defect in lipoprotein lipase (LPL) results in chylomicronemia]] |
Answer E | AnswerE::Defect in chylomicron |
Answer E Explanation | [[AnswerEExp::A defect in chylomicron is not the primary defect in individuals with abetalipoproteinemia, but often it occurs secondary to an MTP gene defect.]] |
Right Answer | RightAnswer::C |
Explanation | [[Explanation::Abetalipoproteinemia is a rare autosomal recessive genetic disease characterized by fat accumulation in enterocytes, fat malabsorption, acanthocytosis, and hypocholesterolemia. Abetalipoproteinemia is caused by mutations in the MTP gene (long arm of chromosome 4) that encodes microsomal triglyceride transfer protein (MTP or MTTP). MTPs are required for the synthesis and post-translational processing of apo-B. As such, abetalipoproteinemia is marked by the complete absence of apo-B-containing lipoproteins, namely VLDL, LDL, and chylomicrons. At older age, abetalipoproteinemia frequently manifests with clinical signs and symptoms associated with fat-soluble vitamin deficiency. Patients often present with complaints related to the GI (steatorrhea and fat malabsorption), ocular (atypical retinitis pigmentosa), hematological (coagulopathy), and neurological (posterior column neuropathy) systems. Educational Objective: Abetalipoproteinemia results from a genetic mutation in the MTP gene. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Abetalipoproteinemia, WBRKeyword::Malabsorption, WBRKeyword::Diarrhea, WBRKeyword::Microsomal triglyceride transfer protein, WBRKeyword::Apolipoprotein, WBRKeyword::MTP, WBRKeyword::MTTP, WBRKeyword::Apo-B, WBRKeyword::Acanthocytosis |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |